---
title: SOX10 mediates glioblastoma cell-state plasticity
date: '2024-09-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39285246/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240917194252&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Phenotypic plasticity is a cause of glioblastoma therapy failure. We
  previously showed that suppressing the oligodendrocyte-lineage regulator SOX10 promotes
  glioblastoma progression. Here, we analyze SOX10-mediated phenotypic plasticity
  and exploit it for glioblastoma therapy design. We show that low SOX10 expression
  is linked to neural stem-cell (NSC)-like glioblastoma cell states and is a consequence
  of temozolomide treatment in animal and cell line models. Single-cell transcriptome
  ...
disable_comments: true
---
Phenotypic plasticity is a cause of glioblastoma therapy failure. We previously showed that suppressing the oligodendrocyte-lineage regulator SOX10 promotes glioblastoma progression. Here, we analyze SOX10-mediated phenotypic plasticity and exploit it for glioblastoma therapy design. We show that low SOX10 expression is linked to neural stem-cell (NSC)-like glioblastoma cell states and is a consequence of temozolomide treatment in animal and cell line models. Single-cell transcriptome ...